Equifax Expects Q1, Annual Results To Improve

Equifax initiated fiscal 2026 guidance, forecasting Q1 adjusted EPS of $1.63–$1.73 on revenue of $1.597B–$1.627B (versus Q1 FY25 adjusted EPS $1.53 and revenue $1.442B) and full-year adjusted EPS of $8.30–$8.70 on revenue of $6.660B–$6.780B (versus FY25 adjusted EPS $7.65 and revenue $6.074B). Guidance assumes U.S. mortgage market down low single digits in 2026 and that 100% of mortgage credit scores will be FICO Scores, reflecting cautious assumptions despite top- and bottom-line year-over-year growth.

Analysis

Market structure: Equifax’s guidance implies FY revenue growth of ~9.7–11.6% (to $6.66–6.78B) and EPS +8.5–13.7% (to $8.30–8.70) despite an assumed US mortgage market down “low single digits” (≈-1% to -4%). Winners: EFX and FICO (higher scoring demand/fees), analytics and commercial data segments; losers: VantageScore providers and mortgage-originator service revenues that scale with origination volume. Cross-asset: lower mortgage issuance mechanically reduces new MBS supply and could modestly tighten credit spreads if recession risk falls; FX/commodities immaterial.

Risk assessment: Key tail risks are (1) a deeper-than-expected housing pullback (>10% drop in mortgage volumes) that would knock 5–15% off guidance, (2) regulatory action over scoring/competition or a data breach causing client attrition, and (3) failure/delay in the assumed “100% FICO” adoption. Near-term (days–weeks) volatility will center on Q1 commentary and FICO contract updates; medium-term (3–12 months) risk is client migration timing; long-term (1–3 years) is secular mortgage decline vs analytics diversification.

Trade implications: The guidance suggests asymmetric upside for EFX vs peers; relative winners are companies with proprietary scoring relationships. Direct trades: structured long exposure to EFX into the next two earnings windows and defensive trimming of mortgage originators and MBS-sensitive REITs. Use options to define downside (calendar or vertical call spreads) and size positions to 1–3% of portfolio given operational/regulatory tail risk.

Contrarian angles: Consensus may underweight the execution risk of moving to “100% FICO” — if lenders drag feet, bookings could disappoint and multiple compresses. Conversely, guidance could be conservative: a 9–12% revenue beat vs 2025 would justify multiple expansion if combined with higher cross-sell ARR. Historic post-breach recoveries show product diversification can sustain valuation even with cyclical mortgage weakness; unintended consequence: higher FICO fees could invite regulatory scrutiny and competitor price pushes.

Key Decisions for Investors

• Establish a 2.5% long position in EFX (ticker EFX) at current levels (~$175) split in three tranches: 40% now, 30% on a 3% pullback, 30% on confirmation of FICO adoption or Q1 beat. Set target +20% (~$210) within 6–12 months and stop-loss at -12% (~$154) to cap breach/regulatory tail risk.
• Buy a defined-risk options spread: buy 6-month EFX 180/220 call spread sized to 0.75% of portfolio notional to capture upside to guidance revisions while capping premium; roll or close on a 15% realized gain or if implied vol jumps >35%.
• Initiate a relative-value pair: long EFX / short TransUnion (TRU) in 0.8:1 market-value ratio sized 1.5% net exposure, target spread appreciation of 15–25% over 3–12 months if EFX converts FICO business and wins share; cut if TRU outperforms EFX by >10% in 30 days.
• Reduce exposure to mortgage-originator equities and mortgage REITs by 20–30% within 30 days (names with heavy origination sensitivity), and redeploy proceeds into financial data/analytics names (EFX, NDAQ) or defensive data subscriptions if EFX guidance holds. Monitor lender scoring announcements and FTC/CFPB filings over next 60 days; any delay in FICO adoption >90 days should trigger re-evaluation and stop-loss adjustments.